11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations.

11 beta-Hydroxysteroid dehydrogenase (11 beta HSD) catalyzes the conversion of corticosterone to inert 11-dehydrocorticosterone, thus regulating glucocorticoid access to intracellular receptors. This type 1 isoform (11 beta HSD-1) is a bidirectional NADPH(H)-dependent enzyme in vitro and is highly expressed in liver, where it is regulated by glucocorticoids, thyroid hormones, estrogen, and GH in vivo. In humans in vivo, enzyme inhibition alters glucose homeostasis, an effect thought to be mediated in the liver. However, detailed investigation of the biology of 11 beta HSD-1 in liver, its function, regulation, and indeed even reaction direction, has been hampered by the lack of clonal hepatic cell lines that express 11 beta HSR-1. Studies of nonhepatic cell lines have suggested that 11 beta HSD-1 is directly regulated by hormones, and transfection of nonhepatic cell lines has sown that reaction direction varies between cell types, possibly reflecting intracellular cosubstrate (NADP+/NADPH) ratios or PH. To investigate reaction direction and gene regulation of 11 beta HSD-1 in hepatocytes, we defined conditions for primary culture of adult rat hepatocytes that maintain high 11 beta HSR-1 messenger RNA expression. In intact primary hepatocytes over a wide range of steroid concentrations (2.5-250 nM), 11 beta-reduction was the predominant reaction direction [33.5 +/- 0.5% conversion of 11-dehydrocorticosterone (25 nM) to corticosterone after 30 min], with undetectable 11 beta-dehydrogenation. However, homogenates of hepatocyte cultures showed plentiful 11 beta-dehydrogenase activity. Treatment of hepatocyte cultures with the metabolic inhibitors sodium azide (5 nM) and KCN (1 nM) altered cellular NADP+/NADPH ratios from 0.244 +/- 0.042 in controls to 0.020 +/- 0.001 and 0.152 +/- 0.009, respectively, but had no effect on 11 beta-reductase or 11 beta- dehydrogenase activity. High concentrations of KCN (10 mM) modestly increased 11 beta-reductase activity (32.4 +/- 1.7% to 48.8 +/- 0.5%, whereas 11 beta-dehydrogenation remained at the limit of detection. Manipulation of culture medium pH (6.2-8.0) had no effect on enzyme activity. Dexamethasone (10-7 M) induced hepatocyte 11 beta-reductase activity from 23.4 +/- 0.7% to only weakly affects reaction direction. Glucocorticoid and insulin regulation of hepatic 11 beta HSD-1 is directly mediated, but other hormonal controls are either lost in culture or mediated indirectly. This primary hepatocyte culture system will allow investigation of the control of 11 beta-reductase activity and its implications for glucocorticoid-regulated hepatic functions.

[1]  C. Edwards,et al.  Cloning, sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  Z. Krozowski,et al.  Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme , 1994, Molecular and Cellular Endocrinology.

[3]  C. Edwards,et al.  'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. , 1994, Journal of molecular endocrinology.

[4]  P. Stewart,et al.  Tissue specific effects of thyroid hormone on 11β-hydroxysteroid dehydrogenase gene expression , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[5]  J. Seckl 11β‐hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation , 1993 .

[6]  C. Edwards,et al.  Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. , 1993, The Journal of endocrinology.

[7]  W. Miller,et al.  Structure and function of the hepatic form of 11 beta-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. , 1993, Endocrinology.

[8]  C. Edwards,et al.  Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. , 1993, Endocrinology.

[9]  A. Náray-Fejes-Tóth,et al.  A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells. , 1993, The Journal of biological chemistry.

[10]  P. White,et al.  11 beta-hydroxysteroid dehydrogenase. , 1993, Vitamins and hormones.

[11]  G. Hammond,et al.  Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. , 1992, Endocrinology.

[12]  C. Edwards,et al.  Differential promoter usage by the rat 11 beta-hydroxysteroid dehydrogenase gene. , 1992, Molecular endocrinology.

[13]  R Langer,et al.  Switching from differentiation to growth in hepatocytes: Control by extracellular matrix , 1992, Journal of cellular physiology.

[14]  P. Stewart,et al.  Tissue localization of 11β-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  P. White,et al.  The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. , 1991, The Journal of biological chemistry.

[16]  E. Hakanson,et al.  Pyridine nucleotide levels under conditions of 5 alpha-dihydrotestosterone-stimulated 17 beta-estradiol formation from estrone and pathway of nicotinamide adenine dinucleotide biosynthesis in placental villi in vitro. , 1991, The Journal of clinical endocrinology and metabolism.

[17]  C. Edwards,et al.  11Beta‐Hydroxysteroid Dehydrogenase Messenger Ribonucleic Acid Expression, Bioactivity and Immunoreactivity in Rat Cerebellum , 1990, Journal of neuroendocrinology.

[18]  S. Teelucksingh,et al.  Potentiation of hydrocortisone activity in skin by glycerrhetinic acid , 1990, The Lancet.

[19]  C. Monder,et al.  Corticosteroid llβ-Dehydrogenase of Rat Tissues: Immunological Studies , 1990 .

[20]  P. White,et al.  Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. , 1989, The Journal of biological chemistry.

[21]  C. Monder,et al.  Purification and Characterization of the Corticosteroid 1lβ-Dehydrogenase Component of the Rat Liver 1lβ-Hydroxysteroid Dehydrogenase Complex* , 1988 .

[22]  J. Funder,et al.  Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. , 1988, Science.

[23]  C. Edwards,et al.  Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. , 1988, The Journal of clinical investigation.

[24]  P. Stewart,et al.  MINERALOCORTICOID ACTIVITY OF LIQUORICE: 11-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY COMES OF AGE , 1987, The Lancet.

[25]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[26]  J. Darnell,et al.  Dependence of liver-specific transcription on tissue organization , 1985, Molecular and cellular biology.

[27]  J. Darnell,et al.  Changes in liver-specific compared to common gene transcription during primary culture of mouse hepatocytes , 1983, Molecular and cellular biology.

[28]  H. Schriefers,et al.  The involvement of the thyroid and adrenal in the regulation of enzyme activities of hepatic and renal steroid metabolism in the rat. , 1979, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[29]  H. Schriefers,et al.  The hormonal regulation of hepatic microsomal 11beta-hydroxysteroid dehydrogenase activity in the rat. , 1978, Acta endocrinologica.